Clinical Trial Update: Use of Indocyanine Green During Pelvic Lymph Node Dissection in Prostate Cancer. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the use of Indocyanine Green during pelvic lymph node dissection in prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymph Node Metastases
• Prostate Cancer

Drugs mentioned

• Indocyanine Green (Indocyanine Green)

Snippet

Sponsor: TC Erciyes University | Conditions: Prostate Cancer, Lymph Node Metastases | Phase 4 | Status: UNKNOWN